New heart drug enters early safety testing
NCT ID NCT07495813
First seen Mar 29, 2026 · Last updated May 27, 2026 · Updated 9 times
Summary
This early-stage study is testing an experimental drug called RO7763505 to see if it is safe and how the body processes it. About 196 participants, including healthy volunteers and people with stable coronary artery disease, will receive either the drug or a placebo. The goal is to gather safety data and understand the drug's effects, not to treat or cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON Plc (LPRA) - Netherlands
RECRUITINGGroningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.